False-negative results in detection of monoclonal proteins by capillary zone electrophoresis: a prospective study.

References 1. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137–42. 2. Yasuda H, Shima N, Nakagawa N, Mochizuki S, Yano K, Fujise N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPD): a mechanism by which OPD/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329–37. 3. Simonet WS, Lacey DL, Dunstan CR, Kelly M, Chang M-S, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309–19. 4. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, et al. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J 1998;12:845–54. 5. Tomoyasu A, Goto M, Fujise N, Mochizuki S, Yasuda H, Morinaga T, et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. Biochem Biophys Res Commun 1998;245:382–7. 6. Yamamoto M, Murakami T, Nishikawa M, Tsuda E, Mochizuki S, Higashio K, et al. Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. Endocrinology 1998;139: 4012–5. 7. Akatsu T, Murakami T, Nishikawa M, Ono K, Shimomiya N, Tsuda E, et al. Osteoclastogenesis inhibitory factor (OCIF) exhibits hypocalcemic effects in normal mice and in hypercalcemia of malignancy. Bone 1998;23:495–8. 8. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, et al. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 1999;14:518–27. 9. Furuya D, Yagihashi A, Yajima T, Kobayashi D, Orita K, Kurimoto M, et al. An immuno-polymerase chain reaction assay for human interleukin-18. J Immunol Methods 2000;238:173–80. 10. Yamaguchi K, Kinosaki M, Goto M, Kobayashi F, Tsuda E, Morinaga T, et al. Characterization of structural domain of human osteoclastogenesis inhibitory factor. J Biol Chem 1998;273:5117–23.